Jpmorgan Chase & CO Lensar, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Lensar, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 250 shares of LNSR stock, worth $2,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$2,612
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LNSR
# of Institutions
48Shares Held
4.72MCall Options Held
12.2KPut Options Held
30.6K-
North Run Capital, LP Wellesley, MA1.1MShares$11.5 Million7.54% of portfolio
-
Park West Asset Management LLC Larkspur, CA811KShares$8.47 Million0.63% of portfolio
-
Dimensional Fund Advisors LP Austin, TX614KShares$6.42 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA489KShares$5.11 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA433KShares$4.53 Million0.0% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $115M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...